Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer

JAMA Oncol. 2020 Apr 1;6(4):587. doi: 10.1001/jamaoncol.2019.6865.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Humans
  • Immune Checkpoint Inhibitors*
  • Neoplasms* / drug therapy
  • Nivolumab / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Immune Checkpoint Inhibitors
  • Nivolumab